Max Robotics — Global Service Robot Directory + US Certification

About

Kirk A. Keegan is a urologic surgeon and researcher whose work centers on advancing surgical techniques for prostate and bladder cancer, with a particular focus on robotic-assisted procedures and postoperative pain management. His most impactful contribution is the landmark study on salvage robotic-assisted laparoscopic radical prostatectomy (RALP), the largest single-institution series at the time, demonstrating that this minimally invasive approach is a viable option for patients with recurrent prostate cancer after primary therapy—a finding that has guided clinical decision-making and earned 79 citations. Keegan has also contributed to the understanding of bladder cancer epidemiology, emphasizing smoking as the dominant modifiable risk factor. In a randomized controlled trial, he compared standard bupivacaine to long-acting liposomal bupivacaine for pain control in laparoscopic urologic surgery, providing evidence that the more expensive formulation does not necessarily offer superior analgesia—a practical insight for cost-conscious surgical care. His work, cited over 100 times, reflects a commitment to improving oncologic outcomes and patient quality of life through rigorous clinical research and innovative surgical practice.